Navigation Links
Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
Date:4/30/2008

vantages compared to transdermal products delivering actives into the bloodstream, including a faster time to market, a relatively easier path to regulatory approval, a cost effective development program, and, most importantly, significant markets and unmet medical needs. These unmet needs include dentistry, as our lidocaine formulation may potentially replace the need to inject patients with lidocaine, as well as possible use as a spray pain reliever for certain types of burns."

"The results of this study were outstanding and clearly demonstrate the superiority of our formulation over existing products. Our extensive experience with the TPM platform delivery system suggests the strong possibility of obtaining similar results when our product is administered to humans," Mr. Rosen said.

About Lidocaine

Lidocaine is a widely used local anesthetic and antiarrhythmic drug. It is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic, and in minor surgery.

The most commonly encountered lidocaine preparations are marketed by Abraxis Pharmaceutical Products under the brand names Xylocaine(R) and Xylocard(R), and as 'Lanacane' topical ointment in the UK, though lidocaine is also found in many other proprietary preparations. It is available as an ointment, jelly, patch, or aerosol for topical use, as an oral solution, and as an injection for local anesthesia.

About Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutrace
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
2. Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
3. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
4. Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial
5. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
6. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
7. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Calif. , Aug. 20, 2014 The National ... Fernando Davila has been successfully treated for a ... by Dr, Anibal R. Gauto , Medical Director of ... at Eisenhower Medical Center in Rancho Mirage, California ... treatment pioneered by Dr. John Crew at Seton ...
(Date:8/20/2014)... , Aug. 20, 2014 Research and ... Report of Pralmorelin" report to their offering. ... providing comprehensive data on Pralmorelin globally and regionally ( ... North America , Latin America ... Pralmorelin This report focuses on three primary areas; ...
(Date:8/20/2014)... DUBLIN , Aug. 20, 2014 ... addition of the "Global Advanced Wound Care ... Geography) - Size, Share, Global Trends, Company Profiles, ... Forecast, 2013 - 2020" report to their ... "Global advanced wound care and closure market (types, ...
Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Global Market Report of Pralmorelin 2Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2
... 2011 3-V Biosciences, Inc. announced today Stephen R. Brady ... (Logo:   http://photos.prnewswire.com/prnh/20100513/LA04336LOGO ) "Steve,s contributions have been ... at 3-V," said Merdad V. Parsey, MD, PhD, 3-V,s Chief ... we continue to build the 3-V team and advance the ...
... 2011 Awarepoint Corporation today announced it conducted its ... and User Group , Viewpoint | 2011, January 23-25, ... http://photos.prnewswire.com/prnh/20100127/LA44915LOGO ) At this exclusive Awarepoint event, ... with other hospitals to share information and use cases ...
Cached Medicine Technology:3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer 2Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights 2Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights 3Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights 4
(Date:8/20/2014)... 2014 (HealthDay News) -- A new study found no ... treatment for high blood pressure increases patients, risk of ... high blood pressure can prevent strokes and other cardiovascular ... high blood pressure may lead to low blood pressure, ... They looked at about 3,100 patients, aged 40 ...
(Date:8/20/2014)... 20, 2014 Get the report here: ... mergermarket presents ‚ÄúDeal Drivers 2014 Half Year Report for ... M&A activity in both North and South America, with ... About Merrill DataSite     , Merrill DataSite is a ... the due diligence process by providing a highly efficient ...
(Date:8/20/2014)... Beach, Florida (PRWEB) August 20, 2014 ... Florida, with the help of their experienced surgeons trained ... of patients to regain their lost or inaccurate vision. ... for performing Lasik surgery is making it possible for ... aging disease which occurs normally in people in the ...
(Date:8/20/2014)... The award-winning plastic surgery group, The Aesthetic ... throughout Houston to a third office, located in Katy, ... building. ACPS plastic surgeon Dr. Rolando Morales said the ... has risen to become one of the largest, most ... since its establishment in 1996 by plastic surgeons Dr. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 According ... Market Research "Multiplexed Diagnostics Market (Technologies: Very High, ... Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, ... Share, Growth, Trends and Forecast, 2013 - 2019", ... USD 2.8 billion in 2012 and is expected ...
Breaking Medicine News(10 mins):Health News:Tight Blood Pressure Control Doesn't Raise Risk of Falls, Study Says 2Health News:Register to Download Merrill DataSite's Report: Deal Drivers 2014 Half Year Report for the Americas 2Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4
... efforts beginning as evacuees leave coastal areas, WASHINGTON, ... Gulf Coast states, the American Red Cross is starting ... Red Cross has relief,operations ready in four states: Alabama, ... storm is urged to prepare, listen to officials,and heed ...
... release is available in Spanish . ... psychiatric diseases, often associated with considerable treatment needs and ... and family (Pini et al., 2005). Previously also labelled ... an episodic, yet lifelong and clinically severe mood (or ...
... found telmisartan offered slight benefit for those unable to ... -- A new study offers a possible alternative to ... blood pressure under control but who cannot tolerate the ... European Society of Cardiology in Munich on Sunday, Canadian ...
... August 31, 2008 -- An international study led by ... to lower blood pressure, reduced the outcome of cardiovascular ... unable to tolerate a widely available and effective standard ... in the Michael G. DeGroote School of Medicine at ...
... Aug. 31, 2008 Many nursing mothers who ... the "superbug" methicillin-resistant Staphylococcus aureus , or MRSA, ... Center physicians, conservative treatment can deal with the problem. ... mastitis, and showed that MRSA was much more likely ...
... Council (ACC) applauds the California Assembly for listening ... bill that would have,needlessly removed safe and essential ... containing bisphenol A has been recently,reaffirmed by scientific ... legislators made the right decision for their consumers,",stated ...
Cached Medicine News:Health News:American Red Cross Relief Efforts Underway for Gustav 2Health News:The ECNP consensus statement on bipolar depression 2Health News:The ECNP consensus statement on bipolar depression 3Health News:The ECNP consensus statement on bipolar depression 4Health News:The ECNP consensus statement on bipolar depression 5Health News:Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics 2Health News:Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke 2Health News:'Superbug' breast infections controllable in nursing mothers, UT Southwestern researchers find 2Health News:ACC Applauds California's Decision to Not Ban Food-Contact Products Containing Bisphenol A 2
... enzyme-linked immunosorbent assay for the ... IgG-class antibodies to Gliadin in ... intended to be used as ... of gastrointestinal disorders, mainly Coeliac ...
... assurance reagent in assays detecting IgG and IgM ... IgM), IgG and IgM antibodies to rubella virus ... antibodies to cytomegalovirus (CMV IgG and IgM), and ... types 1 and 2 (HSV-1 IgG, HSV-1 IgM, ...
... The Titan Procedure is a ... infrared light source to tighten skin ... The Titan heats the dermis to ... epidermis through continuous cooling. In addition, ...
... XLTEK lets you choose how to configure your ... the study to be performed we recommend ... your budget and clinical needs. How do we ... listen. The result? Kortex. The system that lets ...
Medicine Products: